Sherr and colleagues [25,27,28,29] developed a model of TNBC where AHR activation drives properties associated with tumor progression including migration, invasion, expression of CSC markers, and CSC characteristics of enhanced spheroid formation, tumor formation in NOD/SCID mice, and chemoresistance. This evidence concerns the gene AHR and neoplasm.